Bicycle Therapeutics Plc (BCYC)
3.55
-0.09
(-2.47%)
USD |
NASDAQ |
Oct 23, 16:00
3.54
-0.01
(-0.28%)
After-Hours: 20:00
Bicycle Therapeutics Price to Book Value : 0.4857 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.4857 |
| October 22, 2026 | 0.498 |
| October 21, 2026 | 0.4885 |
| October 20, 2026 | 0.4926 |
| October 19, 2026 | 0.4837 |
| October 16, 2026 | 0.4734 |
| October 15, 2026 | 0.4926 |
| October 14, 2026 | 0.4802 |
| October 13, 2026 | 0.4967 |
| October 12, 2026 | 0.5199 |
| October 09, 2026 | 0.5322 |
| October 08, 2026 | 0.5213 |
| October 07, 2026 | 0.5103 |
| October 06, 2026 | 0.5186 |
| October 05, 2026 | 0.5487 |
| October 02, 2026 | 0.4625 |
| October 01, 2026 | 0.4871 |
| September 30, 2026 | 0.5035 |
| September 29, 2026 | 0.4994 |
| September 28, 2026 | 0.5076 |
| September 25, 2026 | 0.5042 |
| September 24, 2026 | 0.5103 |
| September 23, 2026 | 0.4926 |
| September 22, 2026 | 0.5103 |
| September 21, 2026 | 0.4967 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.4994 |
| September 17, 2026 | 0.5035 |
| September 16, 2026 | 0.498 |
| September 15, 2026 | 0.5021 |
| September 14, 2026 | 0.5322 |
| September 11, 2026 | 0.5281 |
| September 10, 2026 | 0.524 |
| September 09, 2026 | 0.548 |
| September 08, 2026 | 0.5719 |
| September 04, 2026 | 0.5883 |
| September 03, 2026 | 0.5801 |
| September 02, 2026 | 0.5883 |
| September 01, 2026 | 0.561 |
| August 31, 2026 | 0.5651 |
| August 28, 2026 | 0.5747 |
| August 27, 2026 | 0.5924 |
| August 26, 2026 | 0.5959 |
| August 25, 2026 | 0.6006 |
| August 24, 2026 | 0.5924 |
| August 21, 2026 | 0.5979 |
| August 20, 2026 | 0.5801 |
| August 19, 2026 | 0.5664 |
| August 18, 2026 | 0.5459 |
| August 17, 2026 | 0.5473 |
| August 14, 2026 | 0.5336 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Autolus Therapeutics Plc | 7.307 |
| DBV Technologies SA | 2.776 |
| Cellectis SA | 2.403 |
| Akari Therapeutics Plc | 0.7742 |
| Biodexa Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PS Ratio | 4.043 |
| Price | 3.55 |
| Earnings Yield | -76.94% |
| Market Cap | 178.84M |